Two-sided sponge treatment for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel – a retrospective series
Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e591-e592
DOI: 10.1055/s-0044-1789684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von R. Käser und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Endoscopic negative pressure therapy (ENT) is a highly effective treatment for anastomotic leaks and perforations in the gastrointestinal tract. However, accurate positioning and application of the sponge into lesions distal to the esophagus or proximal to the rectum is challenging due to its size and flexibility.
Aims
In 2014, a modified ENT technique was proposed – the "two-sided sponge" (TSS) method. With TSS, the sponge system is connected to a percutaneous abdominal drain [1]. Subsequently, the sponge can be maneuvered independently of the endoscope by pulling either the abdominal or the oral drain.
Methods
In this retrospective case series, we report on 57 consecutive cases treated with TSS for leaks and perforations in the upper GI tract and small bowel at our institution between 2012 and 2023. The primary endpoints were healing of the lesion and avoidance of revisional surgery. Secondary endpoints included procedure-related complications, technical data like number of sponge exchanges, length of hospital stay, and in-hospital mortality.
Results
The mean age was 58 (±17) years. The indication for TSS was anastomotic leakage in 65% (37/57) and acute perforation in 35% (20/57) of cases. Lesions were located in the esophagus (26%, 15/57), stomach (35%, 20/57), duodenum (23%, 13/57), and jejunum (16%, 9/57). TSS placement was successful in all cases. Sponges were exchanged every 4-5 days, with a median of 4 sessions needed (range 1-20). The median hospital stay was 66 days (range 6-184). Successful lesion healing with TSS alone occurred in 51% (29/57) of cases. In 18% of cases (10/57), residual leaks after TSS were successfully managed by temporary stent placement. Overall, revisional surgery was avoided in 74% of cases. There were one minor and two major complications (bleeding after removal of the sponge). The in-hospital mortality rate was 19%, with no procedure-related deaths. Follow-up median was 2126 days (range 6-2634)
Conclusions
In summary, two-sided sponge therapy appears safe and effective for treating leaks and perforations in challenging upper GI tract and small bowel locations. Revisional surgery can likely be avoided in most cases. Further studies with larger sample sizes are warranted to fully characterize TSS efficacy for various upper gastrointestinal defects. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Käser, R., Schiemer, M., Mangold, T., Müller, J., Kuvendjiska, J., Fichtner-Feigl, S., Thimme, R., Fischer, A., Schmidt, A., & Küllmer, A. (2024). Two-sided sponge treatment for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel – a retrospective series. Zeitschrift für Gastroenterologie, 62(09), e591-e592. https://doi.org/10.1055/s-0044-1789684
Vancouver
Käser R, Schiemer M, Mangold T, Müller J, Kuvendjiska J, Fichtner-Feigl S, et al. Two-sided sponge treatment for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel – a retrospective series. Zeitschrift für Gastroenterologie. 2024;62(09):e591-e592. doi:10.1055/s-0044-1789684
BibTeX
@article{Kser2024,
author = {Käser, R. and Schiemer, M. and Mangold, T. and Müller, J. and Kuvendjiska, J. and Fichtner-Feigl, S. and Thimme, R. and Fischer, A. and Schmidt, A. and Küllmer, A.},
title = {Two-sided sponge treatment for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel – a retrospective series},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {09},
pages = {e591--e592},
doi = {10.1055/s-0044-1789684}
}
EUVIMED